Literature DB >> 15609382

Impact of a surgical training programme on rectal cancer outcomes in Stockholm.

A Martling1, T Holm, L E Rutqvist, H Johansson, B J Moran, R J Heald, B Cedermark.   

Abstract

BACKGROUND: Total mesorectal excision (TME) and use of adjuvant radiotherapy are major advances in the treatment of rectal cancer that have emerged in the past 20 years. The aim of this study was to evaluate the effects of an initiative to teach the TME technique on outcomes at 5 years after surgery.
METHODS: TME-based surgery was introduced in Stockholm in 1994. The study population comprised all 447 patients who underwent abdominal operations for rectal cancer in Stockholm County during 1995 and 1996. Outcomes were compared with those in the Stockholm I (790 patients) and Stockholm II (542 patients) radiotherapy trials.
RESULTS: The permanent stoma rate was reduced from 60.3 and 55.3 per cent in the Stockholm I and II trials respectively to 26.5 per cent in the TME project (P < 0.001). Five-year local recurrence rates decreased from 21.9 and 19.1 per cent to 8.2 per cent respectively (P < 0.001). Five-year cancer-specific survival rates increased from 66.0 and 65.7 per cent in the Stockholm trials to 77.3 per cent in the TME project (hazard ratio 0.62 (95 per cent confidence interval 0.49 to 0.80); P < 0.001).
CONCLUSION: A surgical teaching programme had a major impact on rectal cancer outcome.

Entities:  

Mesh:

Year:  2005        PMID: 15609382     DOI: 10.1002/bjs.4834

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  50 in total

1.  Increased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excision.

Authors:  Kah Hoong Chang; Myles J Smith; Oliver J McAnena; Arifin S Aprjanto; Joe F Dowdall
Journal:  Int J Colorectal Dis       Date:  2012-03-08       Impact factor: 2.571

2.  Dual-port laparoscopic abdominoperineal resection using the intended stoma site as the multichannel port.

Authors:  Takahisa Ishikawa; Shigenori Homma; Susumu Shibasaki; Tadashi Yoshida; Nozomi Minagawa; Hideki Kawamura; Norihiko Takahashi; Akinobu Taketomi
Journal:  Surg Today       Date:  2015-07-29       Impact factor: 2.549

3.  Factors associated with the location of local rectal cancer recurrence and predictors of survival.

Authors:  Peng Du; John P Burke; Wisam Khoury; Ian C Lavery; Ravi P Kiran; Feza H Remzi; David W Dietz
Journal:  Int J Colorectal Dis       Date:  2016-02-10       Impact factor: 2.571

4.  Preoperative staging for rectal cancer.

Authors:  Ian Finlay
Journal:  BMJ       Date:  2006-10-14

5.  Postoperative morbidity following chemoradiation for locally advanced low rectal cancer.

Authors:  Ingrid Stelzmueller; Matthias Zitt; Felix Aigner; Reinhold Kafka-Ritsch; Robert Jäger; Alexander De Vries; Peter Lukas; Wolfgang Eisterer; Hugo Bonatti; Dietmar Ofner
Journal:  J Gastrointest Surg       Date:  2008-12-11       Impact factor: 3.452

6.  Autonomic nerve preservation during rectal cancer resection.

Authors:  José G Guillem; Steven A Lee-Kong
Journal:  J Gastrointest Surg       Date:  2009-06-23       Impact factor: 3.452

Review 7.  Current concepts in rectal cancer.

Authors:  James W Fleshman; Nathan Smallwood
Journal:  Clin Colon Rectal Surg       Date:  2015-03

Review 8.  Advances and challenges in treatment of locally advanced rectal cancer.

Authors:  J Joshua Smith; Julio Garcia-Aguilar
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

9.  The size of the prize for earlier diagnosis of cancer in England.

Authors:  M A Richards
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

10.  Rectal cancer treatment and outcome in the elderly: an audit based on the Swedish Rectal Cancer Registry 1995-2004.

Authors:  Bärbel Jung; Lars Påhlman; Robert Johansson; Erik Nilsson
Journal:  BMC Cancer       Date:  2009-02-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.